There is no documented evidence that galectin-3 has an effect on hyperdynamic circulation in cirrhosis; therefore, galectin-3 inhibition mainly mediates its effects by reducing inflammation, oxidative stress, apoptosis and fibrosis in the cardiovascular system of cirrhosis. This evidence concerns the gene LGALS3 and Cirrhosis.